A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)
Clinical trial NCT04521751 · COMPLETED
Trial details
- NCT number
- NCT04521751
- Sponsor
- Empros Pharma AB
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-05-07
- Primary completion
- 2021-08-30
- Enrollment
- 156
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.